Search
Descriptor English: Metergoline
Descriptor Spanish: Metergolina
Descriptor metergolina
Scope note: Agonista de la dopamina y antagonista de la serotonina. Se ha utilizado, al igual que la BROMOCRIPTINA, como un agonista de la dopamina y también para el tratamiento de los TRASTORNOS MIGRAÑOSOS.
Descriptor Portuguese: Metergolina
Descriptor French: Métergoline
Entry term(s): Liserdol
Methergoline
Tree number(s): D03.132.327.287.630
D03.633.400.439.630
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008711
Scope note: A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Serotonin Antagonists
Dopamine Agonists
Registry Number: 1501393LY5
CAS Type 1 Name: Carbamic acid, (((8beta)-1,6-dimethylergolin-8-yl)methyl)-, phenylmethyl ester
Previous Indexing: Ergolines (1971-1974)
Public MeSH Note: 2002; see METHERGOLINE 1991-2001, see ERGOLINES 1975-1990
History Note: 2002(1975)
DeCS ID: 8888
Unique ID: D008711
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2017/05/24
Metergoline - Preferred
Concept UI M0013569
Scope note A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy.
Preferred term Metergoline
Entry term(s) Methergoline
Liserdol - Narrower
Concept UI M0474176
Preferred term Liserdol



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey